Spark Investment Management LLC Uni Qure N.V. Transaction History

Spark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$29.75 - $43.08 $211,225 - $305,868	-7,100 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$21.96 - $39.94 $720,288 - $1.31 Million	-32,800 Reduced 82.21%	7,100 $268,000
Q1 2018 May 10, 2018	BUY	$17.1 - $26.61 $682,290 - $1.06 Million	39,900 New	39,900 $937,000
Q4 2017 Feb 12, 2018	SELL	$9.47 - $19.59 $1.53 Million - $3.17 Million	-161,600 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$7.7 - $9.6 $1.24 Million - $1.55 Million	161,600	161,600 $1.55 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.